Skip to main content
Premium Trial:

Request an Annual Quote

Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test

NEW YORK – Epic Sciences announced Friday that it raised $24 million in a Series G financing round, which it will put toward continued development of its DefineMBC multiomic liquid biopsy test for patients with metastatic breast cancer.

Arsenal Capital Partners and Deerfield Management co-led the financing round, and Blue Ox Healthcare Partners, Domain Ventures, and Labcorp also participated.

San Diego-based Epic has now raised a total of $67 million in the past 12 months through multiple financing rounds. The firm plans to use the capital to build out the commercial infrastructure it needs to commercialize DefineMBC, a test designed for circulating tumor cell analysis, single-cell whole genome sequencing, and cell-free DNA sequencing of a 56-gene panel, which also allows the test to deliver insights into tumor mutational burden. These biomarker tests aim to inform best treatment for metastatic breast cancer patients including those for whom a tissue biopsy isn't feasible or available.

Building out the firm's infrastructure includes expanding its sales, product marketing, customer service, medical affairs, payer markets, and billing teams. Epic will also put the additional money toward developing further concordance and outcomes data.

"We have delivered comprehensive test results to 700 patents and their oncologists in our clinical experience program," Epic President and CEO Lloyd Sanders said in a statement. "We have surveyed the physicians participating in the Clinical Experience Program and their responses indicate that oncologists see value in DefineMBC's ability to provide actionable information that allows them to better care for their patients."

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.